Friday, August 8, 2008

The Pitch

TBS seeks $1M to sterilize health-care facilities

By Mass High Tech Staff

TBS Technologies LLC
Headquarters: Holliston
Employees: 4
Founded: 2006
Web: www.tbstechnologies.com
E-mail: tdee@tbstechnologies.com; nstrate@tbstechnologies.com
Phone: Tom Dee: 617-842-5856; Norm Strate: 508-524-8227

The Pitch: TBS is looking to increase product development, commercialization and working capital.

PITCHING THE TECHNOLOGY
TBS Technologies develops products, based on patent-pending technology, that generate and disperse chlorine dioxide gas. The chemical agent was used to clean the Hart Senate Office Building in 2001 after an envelope containing anthrax was mailed to then-Senate majority leader Tom Daschle, and it has been used to clean rooms contaminated with superbugs like MRSA. The company’s product is a hand-held device intended to be used for disinfection, decontamination and sterilization in life sciences and health-care facilities. The product requires the purchase of one-time-use cartridges containing precursor chemicals, and a device that mixes those chemicals into chlorine dioxide gas and disperses it.

PITCHING THE PEOPLE
Who is on the management team? Thomas Dee, CEO, formerly of Ionics Inc.; Norman Strate, president, formerly of Protonex Technology Corp., Hertz Global Holdings Inc., and Showtime Networks Inc.; and Barry Clapp, executive vice president, formerly of Advanced Electron Beams Inc., Source Recovery Co. and IBM Corp.

Who is on the board of advisers? William Carson, formerly of Millipore Corp. and Ionics Inc.; Stephen Korn of Zoll Medical Corp.; Daniel Kuzmak of Terex Corp.; James Mulvihill, formerly of the University of Connecticut Health Center and the Forsyth Institute; Eric Rosenberg of Harvard Medical School and Massachusetts General Hospital; and Paul Sabin of Sabin Design.

PITCHING THE BUSINESS
How much investment is being sought? TBS is seeking $1 million.

What partnerships, collaborations or affiliations are already in place? None.

List any federal or state grants, contracts or awards received: TBS won first place in the recent Worcester Polytechnic Institute Venture Forum Five-Minute Pitch Contest.

What’s the market size being pursued? TBS estimates its market to be more than $3 billion in life sciences and health-care facilities.

Who are the likely competitors, direct or indirect? Competitors include companies making products involving the manual application of liquids. The company said other competitive technologies include formaldehyde and vaporized hydrogen peroxide.

Is the company profitable? No.